Novavax Medical Information
DISCLAIMER: THIS PAGE IS INTENDED FOR HEALTHCARE PROFESSIONALS AND OTHER RELEVANT DECISION MAKERS IN Greece ONLY.
If you are NOT a Healthcare Professional in Greece, please switch to the Consumer Medical Information page.
If you are a Healthcare Professional in another country, please go back to country selection.
Information on the NuvaxovidTM XBB.1.5 dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601)
If your enquiry is regarding the NuvaxovidTM XBB.1.5 dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601), you can find some useful information in the resources below.
Summary of Product Characteristics (SmPC)
Package Leaflet (PL)
Request Medical Information
Do you have a medical or scientific question about a Novavax medicinal product? Get in touch with Novavax Medical Information experts who will provide tailored, evidence-based, balanced, and up-to-date medical information.
Healthcare Professionals may request medical information via ONE of the following ways:
Option 1: Complete and submit a Medical Information Request Form by clicking on the button below.
Option 2: Call +30 21 1198 3631 between 09:00-17:00.
Report an Adverse Event (AE)
If you are concerned about an adverse event, it should be reported to the National Organization for Medicines (EOF) at http://www.eof.gr.
Alternatively, adverse events of serious concern in association with a Novavax product can be reported to Novavax Pharmacovigilance at +30 21 1198 3631 or via the Novavax Adverse Event Reporting Form.
Report a Product Quality Complaint
If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please report the complaint via ONE of the following ways:
Option 1: Complete and submit a Product Quality Complaint Form by clicking on the button below.
Report a Product Quality Complaint
Option 2: Call +30 21 1198 3631 between 09:00-17:00.